News

Bright Peak Therapeutics and Ajinomoto enter into research collaboration for novel immunocytokines

A study published in Nature Medicine points to saliva’s role in SARS-CoV-2 transmission

BetterLife enters research agreement with UCSD for TD-0148A behavioral pharmacology studies

University of Arizona researcher looks beyond traditional causes to find novel therapies

InteRNA publishes preclinical data from investigational microRNA program  

Asher Bio focuses on cis-targeting technology to precisely target discrete immune cell subtypes

AzurRx completes enrollment in Phase 2 clinical trial of MS1819 in combination with PERT to treat cystic fibrosis patients with severe exocrine pancreatic insufficiency

Positive top-line Phase 2 results for AMY-101 in adults with periodontal inflammation and gingivitis

Italfarmaco publishes positive long-term data for givinostat in polycythemia vera patients

Trying to overcome  misinterpretations of the Supreme Court's decisions on patent eligibility by district courts and the Federal Circuit

Algernon Pharmaceuticals submits pre-IND meeting request for clinical research program in DMT for stroke

Roche will acquire the California-based diagnostics company for $1.8 billion